InvestorsHub Logo
Followers 35
Posts 6945
Boards Moderated 0
Alias Born 03/31/2020

Re: raistthemage post# 259377

Tuesday, 03/31/2020 11:08:27 PM

Tuesday, March 31, 2020 11:08:27 PM

Post# of 426485
Now that Judge Du's fresh exciting take on patent law is in the books, settling isn't really an option.

JT, love him or hate him, has always been up front about maximizing company value to patients and investors. AMRN was never advertised nor executed as a quick play. I supported a decisive IP ruling before and support a no-holds appeal strategy now. Judge Du grossly misread the evidence, misapplied the level of proof, and disrupted patents with a new regime for prior art. BP has to be in JT's corner since they have more skin in the IP game. And other patent claims may be asserted (in a different jurisdiction). And the FDA is another matter. And, and... and if all else fails, then doom the bad actors by cozying up to Teva.

Until then, let's all appreciate that Judge Du thanks Amarin and us for our multi-billion wellness charity.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News